Risk-adapted stereotactic body radiation therapy delivered in four fractions in patients with non-small cell lung cancer.
Rattachement africain : jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Risk-adapted stereotactic body radiation therapy is preferred over conventional radiotherapy at the authors' institution based on the hypothesis that even with a lower than recommended dose, stereotactic body radiation therapy would yield better local control than conventional radiotherapy. This retrospective study was performed to verify the hypothesis. Data from 34 patients with non-small cell lung cancer, who underwent risk-adapted stereotactic body radiation therapy delivered in 4 fractions between 2012 and 2018, were analyzed. The 3-year local control rate for patients receiving 42-44 Gy, 40 Gy, and 32-38 Gy was 80.8%, 75.0%, and 66.7%, respectively. The 3-year overall survival rate was 63.5%, 63.5%, and 40.0%, respectively. Three patients experienced grade 3 toxicities, with no toxicities > grade 3 observed. The results support the use of risk-adapted stereotactic body radiation therapy, both with a relatively high dose and a low dose.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
Où se fait cette recherche
-
Izumi City General Hospital Department of Radiology pays non établi dans la noticeÉtablissement de santé
-
Tane General Hospital Department of Radiation Oncology pays non établi dans la noticeÉtablissement de santé
-
Osaka City University pays non établi dans la noticeUniversité ou école supérieure
-
Tokyo Metropolitan University pays non établi dans la noticeUniversité ou école supérieure
-
Osaka Metropolitan University Graduate School of Medicine Department of Radiation Oncology pays non établi dans la noticeUniversité ou école supérieure
Department of Radiology — Izumi City General Hospital, Department of Radiation Oncology — Tane General Hospital et Osaka City University, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.